NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW
3,175.00
-225.00 (-6.62%)
Oct 11, 2024, 9:00 AM KST
NGeneBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5,298 | 19,275 | 24,897 | 16,296 |
Short-Term Investments | 176.59 | 129.05 | 10,021 | 8,011 |
Trading Asset Securities | - | 3,023 | - | - |
Cash & Short-Term Investments | 5,475 | 22,427 | 34,918 | 24,307 |
Cash Growth | -80.72% | -35.77% | 43.66% | - |
Accounts Receivable | 1,670 | 788.95 | 1,125 | 1,574 |
Other Receivables | 32.47 | 228.92 | 51.09 | 58.06 |
Receivables | 1,702 | 1,018 | 1,176 | 1,632 |
Inventory | 2,017 | 1,695 | 2,968 | 1,219 |
Prepaid Expenses | 167.63 | 103.34 | 141.72 | 79.67 |
Other Current Assets | 280.64 | 1,779 | 3,868 | 136.73 |
Total Current Assets | 9,642 | 27,021 | 43,072 | 27,374 |
Property, Plant & Equipment | 13,448 | 9,343 | 8,684 | 8,092 |
Long-Term Investments | 2,781 | 2,837 | 1,378 | 5,451 |
Goodwill | 6,089 | 416.32 | 416.32 | 416.32 |
Other Intangible Assets | 1,387 | 1,456 | 1,224 | 1,247 |
Other Long-Term Assets | 1,293 | 1,208 | 1,389 | 1,287 |
Total Assets | 34,641 | 42,282 | 56,164 | 43,867 |
Accounts Payable | 154.94 | 162.75 | 69.18 | 172.85 |
Accrued Expenses | 388.87 | 253.59 | 235.99 | 188.37 |
Short-Term Debt | 10,137 | 11,056 | 10,786 | 6,100 |
Current Portion of Long-Term Debt | - | - | - | 362 |
Current Portion of Leases | 1,272 | 241.11 | 295.95 | 161.89 |
Current Unearned Revenue | - | 0 | 20.17 | 18.33 |
Other Current Liabilities | 6,425 | 12,103 | 17,594 | 1,051 |
Total Current Liabilities | 18,378 | 23,816 | 29,001 | 8,055 |
Long-Term Debt | - | - | - | 500 |
Long-Term Leases | 1,493 | 146.88 | 374.62 | 82.69 |
Other Long-Term Liabilities | 150.55 | 150.52 | 165.38 | 43.69 |
Total Liabilities | 22,028 | 26,048 | 30,837 | 9,869 |
Common Stock | 12,889 | 12,889 | 12,526 | 12,431 |
Additional Paid-In Capital | 55,195 | 55,102 | 52,570 | 51,982 |
Retained Earnings | -59,288 | -53,941 | -40,886 | -31,381 |
Comprensive Income & Other | 2,317 | 2,244 | 1,086 | 965.73 |
Total Common Equity | 11,114 | 16,295 | 25,297 | 33,998 |
Minority Interest | 1,498 | -60.68 | 30.24 | - |
Shareholders' Equity | 12,612 | 16,234 | 25,327 | 33,998 |
Total Liabilities & Equity | 34,641 | 42,282 | 56,164 | 43,867 |
Total Debt | 12,902 | 11,444 | 11,456 | 7,207 |
Net Cash (Debt) | -7,427 | 10,983 | 23,462 | 17,100 |
Net Cash Growth | - | -53.19% | 37.20% | - |
Net Cash Per Share | -578.71 | 865.85 | 1880.24 | 1382.64 |
Filing Date Shares Outstanding | 12.89 | 12.89 | 12.53 | 12.43 |
Total Common Shares Outstanding | 12.89 | 12.89 | 12.53 | 12.43 |
Working Capital | -8,735 | 3,205 | 14,072 | 19,319 |
Book Value Per Share | 862.27 | 1264.22 | 2019.58 | 2734.94 |
Tangible Book Value | 3,638 | 14,422 | 23,656 | 32,334 |
Tangible Book Value Per Share | 282.25 | 1118.95 | 1888.61 | 2601.11 |
Land | 2,696 | 2,696 | 2,584 | 2,584 |
Buildings | 4,044 | 4,044 | 3,040 | 3,040 |
Machinery | 8,303 | 4,962 | 4,569 | 3,699 |
Construction In Progress | - | - | 9.23 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.